Regulatory Landscape of Regenerative Dermatology: Current Frameworks and Future.
PMID: 41493254 ·
R, a, c, h, e, l, , L, , Z, i, e, b, a, r, t, ;, , B, a, r, b, a, r, a, , H, e, r, n, a, n, d, e, z, -, R, o, v, i, r, a, ;, , H, e, m, a, , S, u, n, d, a, r, a, m, ;, , S, a, m, a, n, t, h, a, , G, u, h, a, n, ;, , S, a, r, a, n, y, a, , P, , W, y, l, e, s
Publicidade
Resumo
Regenerative dermatology is an emerging subspecialty that seeks to restore the structure and function of healthy skin. The United States lacks comprehensive regulatory guidance for regenerative therapies. This review provides an overview of available therapies within regenerative dermatology, outlining the pathways for approval. Articles on regenerative dermatology in PubMed and guidelines issued by the United States Food and Drug Administration (FDA) were reviewed with emphasis on those publish
Publicidade
Fonte oficial
Ver no PubMed →Dados provenientes do PubMed / NCBI. Para consultar o texto integral e as informações mais recentes, recorra sempre ao registo oficial.